Diltiazem Malate

苹果酸地尔硫卓

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiltiazem Malate
Drug Alias NameTiamateMK-793
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-dependent calcium channel gamma-1 subunit blockers
TargetsVoltage-dependent calcium channel gamma-1 subunit
Therapy Area/IndicationsHypertensionAngina PectorisBradycardia
Global Approved IndicationsHypertensionAngina PectorisBradycardia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/10/04
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertensionAngina PectorisBradycardia

Other Information

ATC CodeC05AE03C08DB01
Related LinksWikipediaDrugBankKEGG